Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYBlood research

Next-generation digital polymerase chain reaction assay for BCR::ABL1 in chronic myeloid leukemia: comprehensive validation for standardized measurable residual disease detection

  1. 1BioTNS Co., Ltd., Daejeon, 34183 Republic of Korea
  2. 2Uijeongbu, 11759 Republic of Korea

Related

  1. A Methodology to Evaluate the Efficacy and Patient-Centeredness of a Patient-Facing AI Chatbot: Development and Validation of a Standardized-Patient Method
    T. I. Mamun, A. R. Amogh, J. Rhodes +5
    medRxivPreprintCC BY-NCFull textEpidemiology & public healthmedRxiv
  2. A Framework for Analytical Validation of Genomic DNA-Based Shotgun Metagenomic Next-Generation Sequencing Workflows
    K. Foo, K. Y. Toh, L. Lim +4
    medRxivPreprintAll rights reservedFull textInfectious diseasemedRxiv
  3. Unveiling the neuroinflammatory potential of aspartame in Alzheimer’s disease: A comprehensive network toxicology and experimental validation approach
    Dongyang Li, Xuejun Weng, Yijuan Huang +7
    PLOS OnePeer-reviewedCC BY 4.0ImmunologyNeurologyPLOS
  4. Comprehensive identification of lactate metabolism-related genes in recurrent spontaneous abortion : An observational study integrating bioinformatics and experimental validation
    Daili Tang, Lin Chen, Huiling Zheng +2
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  5. Unraveling the role of MCM7 in cancer: a comprehensive analysis and functional validation from pan-cancer to lung adenocarcinoma
    Xiaozhou Xie, Jie Li, Yuchen Jia +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
BibTeX
@article{kim2026nextgeneration,
  title = {{Next-generation digital polymerase chain reaction assay for BCR::ABL1 in chronic myeloid leukemia: comprehensive validation for standardized measurable residual disease detection}},
  author = {Yong-Hwi Kim and Min-Sik Jang and Shin-Hyun Kim and In-Young Roh and Bong-Suk Kim and Kyung-Mi Kee and Soo-Hyun Kim and Dong-Wook Kim and Jae-Hoon Kim},
  journal = {Blood research},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13675441},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Next-generation digital polymerase chain reaction assay for BCR::ABL1 in chronic myeloid leukemia: comprehensive validation for standardized measurable residual disease detection
AU  - Yong-Hwi Kim
AU  - Min-Sik Jang
AU  - Shin-Hyun Kim
AU  - In-Young Roh
AU  - Bong-Suk Kim
AU  - Kyung-Mi Kee
AU  - Soo-Hyun Kim
AU  - Dong-Wook Kim
AU  - Jae-Hoon Kim
PY  - 2026
DA  - 2026/10/16
JO  - Blood research
UR  - https://europepmc.org/article/PMC/PMC13675441
SN  - 2287-979X
SN  - 2288-0011
ER  -